Markets:

Overview

News

Currencies

International

Treasuries

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

12.19 -0.25 (-2.01%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures

July 26, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market

July 13, 2022

From Orthofix Medical Inc.

Via Business Wire

Looking Into Orthofix Medical's Return On Invested Capital ↗

June 01, 2022

According to Benzinga Pro data, during Q1, Orthofix Medical (NASDAQ:OFIX) posted sales of $106.42 million. Earnings were up 86.41%, but Orthofix Medical still reported an overall loss of $4.46...

Via Benzinga

Recap: Orthofix Medical Q1 Earnings ↗

May 06, 2022

Orthofix Medical (NASDAQ:OFIX) reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years

May 31, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference

May 16, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Reports First Quarter 2022 Results

May 06, 2022

From Orthofix Medical Inc.

Via Business Wire

Earnings Scheduled For May 6, 2022 ↗

May 06, 2022

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.

Via Benzinga

Earnings Outlook For Orthofix Medical ↗

May 05, 2022

Orthofix Medical (NASDAQ:OFIX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Orthofix...

Via Benzinga

FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions

May 04, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix and MTF Biologics Expand Partnership Agreement

May 03, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical Q1 2022 Earnings Conference Call On May 6, 2022 At 08:30 AM ET ↗

April 29, 2022

Orthofix Medical (NASDAQ:OFIX) will host a conference call at 08:30 AM ET on May 6, 2022, to discuss Q1 2022 earnings results. How to Attend Orthofix Medical (OFIX) Conference Call Follow this link to...

Via Benzinga

Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022

April 28, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces New Business Unit President

April 08, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System

March 16, 2022

From Orthofix Medical Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022 ↗

March 04, 2022

Upgrades According to Susquehanna, the prior rating for Knight-Swift Transportation Holdings Inc (NYSE:KNX) was changed from Neutral to Positive. Knight-Swift earned $1.61 in the...

Via Benzinga

Orthofix Medical Earnings Perspective: Return On Capital Employed ↗

February 28, 2022

Benzinga Pro data, Orthofix Medical (NASDAQ:OFIX) reported Q4 sales of $125.06 million. Earnings fell to a loss of $32.81 million, resulting in a 1411.38% decrease from last...

Via Benzinga

Recap: Orthofix Medical Q4 Earnings ↗

February 25, 2022

Orthofix Medical (NASDAQ:OFIX) reported its Q4 earnings results on Friday, February 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results

February 25, 2022

From Orthofix Medical Inc.

Via Business Wire

Earnings Scheduled For February 25, 2022 ↗

February 25, 2022

Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...

Via Benzinga

Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures

February 22, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25, 2022

February 10, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems

January 19, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results

January 10, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Appointment of Thomas A. West to Board of Directors

December 14, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical's Return on Invested Capital Overview ↗

November 08, 2021

Benzinga Pro data, Orthofix Medical (NASDAQ:OFIX) reported Q3 sales of $112.43 million. Earnings fell to a loss of $313.00 thousand, resulting in a 107.34% decrease from last...

Via Benzinga

Orthofix Medical inc (OFIX) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

OFIX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill ↗

November 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To...

Via Benzinga

Orthofix Reports Third Quarter 2021 Results

November 05, 2021

From Orthofix Medical Inc.

Via Business Wire

Earnings Scheduled For November 5, 2021 ↗

November 05, 2021

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEPC) is projected to report earnings for its third quarter. • Healthcare Trust (NYSE:HTA) is...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.